✦ LIBER ✦

Model System for High-Throughput Screening of Novel Human Immunodeficiency Virus Protease Inhibitors in Escherichia coli

✍ Scribed by Cheng, T.-J.; Brik, A.; Wong, C.-H.; Kan, C.-C.

Book ID: 126928909
Publisher: American Society for Microbiology
Year: 2004
Tongue: English
Weight: 594 KB
Volume: 48
Category: Article
ISSN: 0066-4804
DOI: 10.1128/aac.48.7.2437-2447.2004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Novel Dengue Virus Inhibitor, BP13944,

A Novel Dengue Virus Inhibitor, BP13944, Discovered by High-Throughput Screening with Dengue Virus Replicon Cells Selects for Resistance in the Viral NS2B/NS3 Protease

✍ Yang, C.-C.; Hu, H.-S.; Wu, R.-H.; Wu, S.-H.; Lee, S.-J.; Jiaang, W.-T.; Chern, 📂 Article 📅 2013 🏛 American Society for Microbiology 🌐 English ⚖ 885 KB

Establishment of an in vitro assay syste

Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography

✍ Kenji Sudo; Hiroshi Inoue; Yasuaki Shimizu; Kayo Yamaji; Kenji Konno; Shiro Shig 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 809 KB

Development of Activity Assays for High-

Development of Activity Assays for High-Volume Evaluation of Human Immunodeficiency Virus (HIV) Protease Inhibitors in Rat Serum: Results with Ditekiren

✍ Karen F. Wilkinson; Bob D. Rush; Satish K. Sharma; David B. Evans; Mary J. Ruwar 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 762 KB

High throughput screening of 16 million

High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan

✍ Hideko Mine; Hiroyuki Emura; Masaki Miyamoto; Tsugikazu Tomono; Kiyoshi Minegish 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Establishment of an in vitro assay syste

Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography: Kenji Sudo1,3, Hiroshi Inoue1, Yasuaki Shimizu2, Kayo Yamaji2, Kenji Konno1, Shiro Shigeta3, Takashi Kaneko4, Tomoyuki Yokota1, and Kunitada Shimotohno4, Rational Drug Design Laboratories1, Fukushima 960-12, Molecular Medicine Research Laboratories, Yamanouchi Pharmaceutical Co. Ltd.2, Tsukuba-shi, Ibaraki 305, Department of Microbiology, Fukushima Medical College3, Fukushima 960-12, Virology Division, National Cancer Center Research Institute4, Tokyo 104, Japan

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 113 KB